Epidemiology of hepatocellular carcinoma in the Asia-Pacific region

Gut and Liver

Volumn 10, Issue 3, 2016, Pages 332-339

  Zhu, Ran Xu ^a   Seto, Wai Kay ^a,b   Lai, Ching Lung ^b   Yuen, Man Fung ^b  

^a THE UNIVERSITY OF HONG KONG SHENZHEN HOSPITAL   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Carcinoma; Hepatocellular; Incidence; Liver neoplasms; Mortality; Prevalence

Indexed keywords

AFLATOXIN B1; ALCOHOL; ANTIVIRUS AGENT; VIRUS DNA; AFLATOXIN;

AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ANTIVIRAL THERAPY; AUSTRALIA; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER THERAPY; CHINA; CHRONIC HEPATITIS B; CHRONIC HEPATITIS C; DRUG EFFICACY; EARLY DIAGNOSIS; FOOD CONTAMINATION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HONG KONG; HUMAN; INDIA; JAPAN; KOREA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREVALENCE; PUBLIC HEALTH PROBLEM; REVIEW; RISK FACTOR; SEX RATIO; SINGAPORE; TAIWAN; ADVERSE EFFECTS; ASIA; CARCINOMA, HEPATOCELLULAR; COMPLICATION; DIABETES MELLITUS, TYPE 2; DRINKING BEHAVIOR; FEMALE; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; INCIDENCE; LIVER NEOPLASMS; MALE; PACIFIC ISLANDS; STATISTICS AND NUMERICAL DATA;

AFLATOXINS; AGE DISTRIBUTION; ALCOHOL DRINKING; ASIA; CARCINOMA, HEPATOCELLULAR; DIABETES MELLITUS, TYPE 2; FEMALE; FOOD CONTAMINATION; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HUMANS; INCIDENCE; LIVER NEOPLASMS; MALE; OCEANIA; PREVALENCE; RISK FACTORS;

EID: 84969268030     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl15257     Document Type: Review

References (68)

1. Boyle P, Levin B. World cancer report 2008. Lyon: IARC Press, 2008
2. Ahmed F, Perz JF, Kwong S, Jamison PM, Friedman C, Bell BP. National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis 2008;5:A74
3. Kew MC. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris) 2010;58:273-277
4. Lai CL, Ratziu V, Yuen MF, Poynard T. Viral hepatitis B. Lancet 2003;362:2089-2094
5. Nordenstedt H, White DL, El-Serag HB. The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis 2010;42 Suppl 3:S206-S214
6. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002 CA Cancer J Clin 2005;55:74-108
7. Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 2010;7:448-458
8. Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008;14:4300-4308
9. Di Bisceglie AM. Epidemiology and clinical presentation of hepatocellular carcinoma. J Vasc Interv Radiol 2002;13(9 Pt 2):S169-S171
10. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557-2576
11. Poon D, Anderson BO, Chen LT, et al. Management of hepatocellular carcinoma in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol 2009;10:1111-1118
12. Montalto G, Cervello M, Giannitrapani L, Dantona F, Terranova A, Castagnetta LA. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci 2002;963:13-20
13. Blumberg BS, Larouzé B, London WT, et al. The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol 1975;81:669-682
14. Block TM, Mehta AS, Fimmel CJ, Jordan R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 2003;22:5093-5107
15. McGlynn KA, London WT. Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol 2005;19:3-23
16. Nguyen VT, Razali K, Amin J, Law MG, Dore GJ. Estimates and projections of hepatitis B-related hepatocellular carcinoma in Aus-tralia among people born in Asia-Pacific countries. J Gastroenterol Hepatol 2008;23:922-929
17. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295:65-73
18. Chen CJ, Yang HI, Iloeje UH; REVEAL-HBV Study Group. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 2009;49(5 Suppl):S72-S84
19. Chen JD, Yang HI, Iloeje UH, et al. Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death. Gastroenterology 2010;138:1747-1754
20. Han YF, Zhao J, Ma LY, et al. Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma. World J Gastroenterol 2011;17:4258-4270
21. Tseng TC, Liu CJ, Chen CL, et al. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers. J Infect Dis 2013;208:584-593
22. Geier A, Gartung C, Dietrich CG. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002;347:1721-1722
23. Sunbul M. Hepatitis B virus genotypes: global distribution and clinical importance. World J Gastroenterol 2014;20:5427-5434
24. Chan HL, Hui AY, Wong ML, et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 2004;53:1494-1498
25. Tseng TC, Liu CJ, Yang HC, et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology 2012;142:1140-1149.e3
26. Lu SN, Lin TM, Chen CJ, et al. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 1988;62:2051-2055
27. Fasani P, Sangiovanni A, De Fazio C, et al. High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors. Hepatology 1999;29:1704-1707
28. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006;118:3030-3044
29. But DY, Lai CL, Yuen MF. Natural history of hepatitis-related hepatocellular carcinoma. World J Gastroenterol 2008;14:1652-1656
30. Donato F, Tagger A, Gelatti U, et al. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am J Epidemiol 2002;155:323-331
31. Colombo M, de Franchis R, Del Ninno E, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1991;325: 675-680
32. Zhang YJ, Chen Y, Ahsan H, et al. Silencing of glutathione Stransferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma. Cancer Lett 2005;221:135-143
33. Ghebranious N, Sell S. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice. Hepatology 1998;27:383-391
34. Wang P, Kang D, Cao W, Wang Y, Liu Z. Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and metaanalysis. Diabetes Metab Res Rev 2012;28:109-122
35. Wang C, Wang X, Gong G, et al. Increased risk of hepatocellular carcinoma in patients with diabetes mellitus: a systematic review and meta-analysis of cohort studies. Int J Cancer 2012;130:1639-1648
36. Davila JA, Morgan RO, Shaib Y, McGlynn KA, El-Serag HB. Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study. Gut 2005;54:533-539
37. Ohishi W, Fujiwara S, Cologne JB, et al. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2008;17:846-854
38. Law MG, Roberts SK, Dore GJ, Kaldor JM. Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality. Med J Aust 2000;173:403-405
39. Kemp W, Pianko S, Nguyen S, Bailey MJ, Roberts SK. Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease. J Gastroenterol Hepatol 2005;20:873-881
40. Walter SR, Thein HH, Gidding HF, et al. Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C. J Gastroenterol Hepatol 2011;26:1757-1764
41. O'Sullivan BG, Gidding HF, Law M, Kaldor JM, Gilbert GL, Dore GJ. Estimates of chronic hepatitis B virus infection in Australia, 2000 Aust N Z J Public Health 2004;28:212-216
42. Amin J, O'Connell D, Bartlett M, et al. Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study. Aust N Z J Public Health 2007;31:475-482
43. Tanaka M, Katayama F, Kato H, et al. Hepatitis B and C virus infection and hepatocellular carcinoma in China: a review of epidemiology and control measures. J Epidemiol 2011;21:401-416
44. Fan JH, Wang JB, Jiang Y, et al. Attributable causes of liver cancer mortality and incidence in china. Asian Pac J Cancer Prev 2013;14:7251-7256
45. Zhou X, Tang Z, Yu Y. Changing prognosis of primary liver cancer: some aspects to improve long-term survival. Zhonghua Zhong Liu Za Zhi 1996;18:211-213
46. Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X. Report of cancer incidence and mortality in China, 2010. Ann Transl Med 2014;2:61
47. Lin J. A study on aetiological factors of primary hepato-carcinoma in Tianjin China. Zhonghua Liu Xing Bing Xue Za Zhi 1991;12: 346-349
48. Chen JG, Zhu J, Parkin DM, et al. Trends in the incidence of cancer in Qidong, China, 1978-2002. Int J Cancer 2006;119:1447-1454
49. Hong Kong Cancer Registry. Overview of Hong Kong cancer statistics [Internet]. Hong Kong: Hospital Authority; 2015 [cited 2015 Apr 15]. Available from http://www3.ha.org.hk/cancereg/Statistics.html#cancerfacts
50. Yuen MF, Cheng CC, Lauder IJ, Lam SK, Ooi CG, Lai CL. Early detection of hepatocellular carcinoma increases the chance of treat ment: Hong Kong experience. Hepatology 2000;31:330-335
51. Yeole BB. Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India. Asian Pac J Cancer Prev 2008;9:97-100
52. Kumar M, Kumar R, Hissar SS, et al. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. J Gastroenterol Hepatol 2007;22:1104-1111
53. Tanaka H, Imai Y, Hiramatsu N, et al. Declining incidence of hepatocellular carcinoma in Osaka, Japan, from 1990 to 2003. Ann Intern Med 2008;148:820-826
54. Umemura T, Ichijo T, Yoshizawa K, Tanaka E, Kiyosawa K. Epidemiology of hepatocellular carcinoma in Japan. J Gastroenterol 2009;44 Suppl 19:102-107
55. Park JW. Hepatocellular carcinoma in Korea: introduction and overview. Korean J Gastroenterol 2005;45:217-226
56. Medical Council of New Zealand. Best health outcomes for Pacific peoples: practice implications. Wellington: Medical Council of New Zealand, 2010
57. Meredith I, Sarfati D, Ikeda T, Blakely T. Cancer in Pacific people in New Zealand. Cancer Causes Control 2012;23:1173-1184
58. Fernandes ML, Chan YH, Lim SG. Trends in the incidence of hepatocellular carcinoma in Singapore 1968-2002. Hepatology 2007;46(4 Suppl 1):418A
59. Lu SN, Su WW, Yang SS, et al. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int J Cancer 2006;119:1946-1952
60. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children: Taiwan Childhood Hepatoma Study Group. N Engl J Med 1997;336:1855-1859
61. Yuen MF, Hou JL, Chutaputti A; Asia Pacific Working Party on Prevention of Hepatocellular Carcinoma. Hepatocellular carcinoma in the Asia pacific region. J Gastroenterol Hepatol 2009;24:346-353
62. Klevens RM, Hu DJ, Jiles R, Holmberg SD. Evolving epidemiology of hepatitis C virus in the United States. Clin Infect Dis 2012;55 Suppl 1:S3-S9
63. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013 Lancet 2015;386:1546-1555
64. Lai CL, Lam KC, Wong KP, Wu PC, Todd D. Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong. Cancer 1981;47:2746-2755
65. Lai CL, Gregory PB, Wu PC, Lok AS, Wong KP, Ng MM. Hepatocellular carcinoma in Chinese males and females: possible causes for the male predominance. Cancer 1987;60:1107-1110
66. Shiu W, Dewar G, Leung N, et al. Hepatocellular carcinoma in Hong Kong: clinical study on 340 cases. Oncology 1990;47:241-245
67. Leung NW, Tam JS, Lai JY, et al. Does hepatitis C virus infection contribute to hepatocellular carcinoma in Hong Kong? Cancer 1992;70:40-44
68. Cheung TK, Lai CL, Wong BC, Fung J, Yuen MF. Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong. Aliment Pharmacol Ther 2006;24:573-583